NHS officials estimate around 50 people a year will receive treatment now it has been approved for use for certain patients with severe sickle cell disease. | ITV National News ...
The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...
NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...